LLBO (LLBO) Stock Price & Analysis
LLBO (LLBO) rose 0.00% to USD 0 as of July 25, 2026 at 05:39 UTC, according to Nexqual real-time market data.
LLBO last closed at USD 0; the session ranged USD 0–0 on volume of 135,612 shares. Market capitalization is $2.17M, with a 52-week range of USD 0–0 (OID). Source: Nexqual, July 25, 2026 at 05:39 UTC.
Key Statistics (as of July 25, 2026 at 05:39 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 135,612 shares |
| Market Cap | $2.17M |
| Exchange | OID |
Technical Analysis (LLBO)
Nexqual's technical model rates LLBO "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of July 25, 2026 at 05:39 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.58 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (LLBO)
Wall Street analysts rate LLBO "None", per Nexqual as of July 25, 2026 at 05:39 UTC.
| Consensus Rating | None |
|---|
Earnings (LLBO)
Source: Nexqual, July 25, 2026 at 05:39 UTC.
Financials & Fundamentals (LLBO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Debt / Equity | 7.89 |
| Current Ratio | 8.42 |
| Total Cash | $603,322 |
| Total Debt | $481,572 |
Source: Nexqual, July 25, 2026 at 05:39 UTC.
Financial Health Score (LLBO)
Nexqual rates LLBO's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 05:39 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Strong — $603K cash, no debt |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (LLBO)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 4.35B |
| Float | 2.58B |
Source: Nexqual, July 25, 2026 at 05:39 UTC.
Leadership (LLBO)
LLBO is led by Caren D. Currier (age 62), President & CEO, per Nexqual as of July 25, 2026 at 05:39 UTC.
| President & CEO | Caren D. Currier (age 62) |
|---|---|
| Treasurer & Chairman | James D. Holmes |
| Vice President, Medical Director, Secretary and Director | Louis G. Keith |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIEL | BioElectronics Corp. | USD 0 | ▲ 0% |
| ASFX | AMERICAN SCIENTIFIC RESOURCES I | USD 0 | ▲ 0% |
| IGNT | INGEN TECHNOLOGIES INC | USD 0 | ▲ 0% |
| HTDS | HARD TO TREAT DISEASES INC | USD 0 | ▲ 0% |
| PDMI | Paradigm Medical Industries, In | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:39 UTC. This page is informational and not investment advice.